Page 1232 - Adams and Stashak's Lameness in Horses, 7th Edition

1198 Index

pastern (cont’d) ilial wing fractures, 771, 772 growth and development of the
musculoskeletal system, 1033
osteochondral fractures, 524–525 prognosis, 771 hypertrophy zone, 1036
pubis and ischium, 773, 774
VetBooks.ir fractures of the proximal (first) phalanx sacrum, 775 immature skeleton, effect of trauma, 820
prognosis, 525
treatment, 524–525
on‐site management, 771
proliferative zone, 1035–1036
resting/reserve zone, 1035
treatment, 771
(P1), 525–532
tuber coxae fractures, 771–773
classification, 526, 527, 528
zone of calcification/ossification, 1036
clinical signs, 529 nuclear medicine vascularity of the physis, 1036
comminuted P1 fractures, 527, 531–532 abnormal conditions, 368, 371, 370 physitis
diagnosis, 529 normal bone, 353–355 clinical signs, 1043
etiology, 527–528 palpation and manipulation, 113, 114 diagnosis, 1043–1045
noncomminuted P1 fractures, 526, 527, radiography, 288 epiphysitis/physitis/physeal dysplasia,
528, 529–530, 532 Thoroughbred racehorses, common 1042–1046
prognosis, 532 conditions, 959–960 etiology, 1042–1043
treatment, 529–532 thrombosis of the caudal aorta or the iliac infectious physitis, 839
functional anatomy, 9–12 arteries, 775 prognosis, 1046
long sloping pastern, forelimb clinical signs, 775 treatment, 1046
conformation, 84–85 diagnosis, 775 PIP joint see proximal interphalangeal joint
luxation/subluxation of the proximal prognosis, 775 platelet‐rich plasma (PRP)
interphalangeal (PIP) joint, 518–522 treatment, 775 intralesional therapies, 897–898
clinical signs, 520–521 PEMF (pulsed electromagnetic field) therapy, intrasynovial therapies, 890–891
diagnosis, 521 rehabilitation/physical therapy, 941 polyacrylamide hydrogel (PAAG),
etiology, 520 penetrating injuries of the foot, 481–483 intrasynovial therapies, 891–892
prognosis, 521–522 clinical signs, 481–482 Polyglycan ® , intrasynovial therapies, 890
treatment, 521 diagnosis, 482 polysulfated glycosaminoglycans (PSGAGs),
osteoarthritis (OA) of the PIP joint (high prognosis, 483 875–876
ringbone), 512–517 treatment, 482–483 intralesional therapies, 896
clinical signs, 513–514 pentosan polysulfate (PPS), 875–876 intrasynovial therapies, 452, 889–890
conservative management, 515–516 periarticular tarsal cellulitis, 697–698 poorly performing horse, 1161–1165
diagnosis, 514–515 perinatal and congenital conditions, clinical examination, 1163–1164
etiology, 512–513 foals, 1088 diagnostics, 1164–1165
prognosis, 517 perineural anesthesia, 157–167 history, 1161–1163
surgical treatment, 516–517 forelimb, 159–164 signalment, 1161–1163
treatment, 515–517 abaxial sesamoid block, 160 treatment, 1165
osteochondrosis (OC) of the PIP joint, basisesamoid or high PD block, 160 types of poor performance problems, 1161,
517–518 high 2‐point block, 162–163 1162–1163
clinical signs, 518 high palmar (high 4‐point block), positron emission tomography (PET),
diagnosis, 518 161–162 383, 385
etiology, 518 lateral palmar block (lateral see also computed tomography
prognosis, 518 approach), 162 PPE see prepurchase examination
treatment, 518, 519 lateral palmar block (medial approach), PPS (pentosan polysulfate), 875–876
palpation and manipulation, 96, 97 162, 163 prepurchase examination (PPE), 1170–1175
short upright pastern, forelimb low palmar block (low 4‐point block), AAEP guidelines for prepurchase
conformation, 84 160–161 report, 1175
Standardbred racehorses, lameness medial cutaneous antebrachial blocks, diagnostic testing, 1173
conditions, 966 163–164 dynamic examination, 1172–1173
superficial digital flexor tendon (SDFT), median nerve block, 163–164 interpretation of findings and
abnormalities, 9–10, 536–539, 537 palmar digital (PD) block, 159 reporting, 1174
Thoroughbred racehorses, common pastern ring or semi‐ring block, 159, 160 musculoskeletal examination, 1172
conditions, 952 ulnar block, 163–164 nuclear medicine, 1174
ultrasonography, 303–304, 313, 314, guidelines, 158 physical examination, 1172–1173
319, 320 hindlimb, 164–167 radiography, 1173–1174
patella deep branch of the lateral plantar nerve structure of the prepurchase examination,
see also femoropatellar joint (DBLPN) block, 164–165 1171–1174
radiography, 286 high plantar block, 164 ultrasonography, 1174
patellar fractures, jumping/eventing/ peroneal block, 165–167 PRM see pelvic rotation movement
dressage, 996 tibial block, 165–167 proportions and curvature of the top line,
patellar luxation/subluxation, 721–722 peroneus tertius rupture, subjective examination for lameness, 76–77
clinical signs, 721 assessment of lameness, 126 proprioceptive facilitation/neuromotor
diagnosis, 721 phalangeal/fetlock/distal limb flexion, control techniques, rehabilitation/
etiology, 721 palpation and manipulation, 115–117 physical therapy, 934–936
prognosis, 721–722 phalanges, radiography, 222–223 proximal (first) phalanx (P1)
treatment, 721 phalanges and distal metacarpus, fracture fractures, 525–532
patella upward fixation see upward fixation management, 1145, 1146, 1147 classification, 526, 527, 528
of the patella phalanges and distal metatarsus, fracture clinical signs, 529
pelvic limb management, 1148, 1150 comminuted P1 fractures, 527, 531–532
nuclear medicine, 346 phenylbutazone see nonsteroidal anti‐ diagnosis, 529
stay apparatus of the pelvic limb, 58–60 inflammatory drugs etiology, 527–528
pelvic rotation movement (PRM), hindlimb physeal fractures, foals, lameness in, 1087 noncomminuted P1 fractures, 526, 527,
lameness, 131–132, 133, 133 physical therapy/rehabilitation see 528, 529–530, 532
pelvis, 770–775 rehabilitation/physical therapy prognosis, 532
foals, lameness in, 1086–1087 physis, 1033–1046 treatment, 529–532
fractures biomechanical aspects of the physis, 1036 osteochondral fractures and fragmentation
acetabular fractures, 774–775 cessation of physeal growth, 1036–1037 of the proximal phalanx, 541–543
clinical examination and signs, 770 classification and treatment of physeal clinical signs, 541
coccygeal vertebrae, 775 injuries/fractures, 1037–1041 diagnosis, 541, 542
diagnosis, 770–771 endochondral ossification of the physis etiology, 541
etiology, 770 (growth plate), 1033–1035 prognosis, 543
ilial shaft fractures, 773–774 external trauma to the physis, 1037 treatment, 542–543